Overall results indicate that on one hand PrtA/curdlan immunization activated antigen-specific antibody and IL-17A response in the mice, but on the other, it failed to protect against pneumococcal pneumonia and invasive infection. This evidence concerns the gene IL17A and pneumococcal pneumonia.